These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23156081)

  • 21. Effects of glycine, chlorpromazine and apomorphine on brain monoamines and free amino acids in rats.
    Koyuncuoğlu H; Atamer-Simşek S; Keyer-Uysal M; Sağduyu H
    Pharmacol Res Commun; 1983 Jan; 15(1):53-61. PubMed ID: 6828543
    [No Abstract]   [Full Text] [Related]  

  • 22. Ethanol and acetaldehyde effects on metabolism and binding of biogenic amines.
    Lahti RA; Majchrowicz E
    Q J Stud Alcohol; 1974 Mar; 35(1):1-14. PubMed ID: 4151232
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of (+/-)-6-fluorotryptophan on sleep and brain monoamine levels in the rat [proceedings].
    Fletcher A; Sugden D
    Br J Pharmacol; 1977 Nov; 61(3):485P-486P. PubMed ID: 588835
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute and chronic effects of carpipramine, clozapine, haloperidol and sulpiride on the metabolism of biogenic amines in the rat brain (author's transl)].
    von Stralendorff B; Ackenheil M; Zimmermann J
    Arzneimittelforschung; 1976; 26(6):1096-8. PubMed ID: 9108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ketamine on brain monoamine levels in rats.
    Kari HP; Davidson PP; Kohl HH; Kochhar MM
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):475-88. PubMed ID: 674827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of p-chlorophenyl alanine on brain amines and drugs induced sleep.
    Navarro G; Lorenzen L
    Proc West Pharmacol Soc; 1975; 18():244-5. PubMed ID: 126455
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of carbidine, sulpiride and haloperidol on levels of monoamines and their metabolites in the brain structures of rats].
    Miroshnichenko II; Kudrin VS; Raevskiĭ KS
    Farmakol Toksikol; 1988; 51(2):26-9. PubMed ID: 2897932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of ethanol on the level of biogenic amines and activity of energy metabolism enzymes in rats subjected to extreme conditions].
    Moshkov KA; Nikolaev IuV; Zaĭtsev IuV; Bul'on VV; Burmistrov SO
    Mol Gen Mikrobiol Virusol; 1986 Nov; (11):30-6. PubMed ID: 3821757
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of compound 48/80 on mast cells and biogenic amine levels in brain structures and on corticosterone secretion.
    Bugajski AJ; Chłap Z; Bugajski J; Borycz J
    J Physiol Pharmacol; 1995 Dec; 46(4):513-22. PubMed ID: 8770794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of chlorpromazine administered to pregnant and lactating rat females on the behaviour of their offspring and its brain content of bioamines.
    Szkilnik R; Brus R; Felińska W; Juraszczyk Z; Pyka U; Piechocka J; Kamiński M; Konecki J
    Acta Med Pol; 1987; 28(1-4):1-12. PubMed ID: 3506370
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of deserpidine and pargyline on the levels of biogenic amines in brain, liver and heart of mice.
    Everett GM; Borcherding J; Morse P
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):245-8. PubMed ID: 4679851
    [No Abstract]   [Full Text] [Related]  

  • 35. Stress-induced changes in brain level of biogenic amines modified by an indigenous drug.
    Upadhyay L; Tiwari AK; Agrawal A; Dubey GP
    Act Nerv Super (Praha); 1990 Jun; 32(2):128-9. PubMed ID: 2399783
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biochemicals and their functions in the brain--glucose, and amino acid and amine neurotransmitters].
    Kashiwamata S; Semba R; Aoki E
    No To Shinkei; 1989 Sep; 41(9):851-61. PubMed ID: 2574048
    [No Abstract]   [Full Text] [Related]  

  • 37. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of compounds structurally related to 5,6-dihydroxytryptamine on behavior and brain biogenic amines in the rat.
    Donelson AC; Manian AA; Maickel RP
    Res Commun Chem Pathol Pharmacol; 1982 Dec; 38(3):517-20. PubMed ID: 7163644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse strain-dependent effect of amantadine on motility and brain biogenic amines.
    Messiha FS
    Arch Int Pharmacodyn Ther; 1989; 302():74-85. PubMed ID: 2484011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the metabolism of biogenic amines in rats with varying resistance to stress, subjected to prenatal hypoxia].
    Gromova EA; Fast AE; Katkov IuA
    Biull Eksp Biol Med; 1988 Jul; 106(7):14-7. PubMed ID: 3401567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.